USA Today: Some Top Medicare Beneficiaries Spend Heavily To Lobby
The 10 drug companies that make the most money from doctors using their products on Medicare patients spent more than $236 million to lobby Congress and the executive branch between 2009 and 2013, according to lobbying records compiled by the Center for Responsive Politics and new federal data. Those efforts came as lawmakers crafted the sweeping Affordable Care Act and as federal regulators have sought new ways to contain costs in Medicare, the federal insurance program for seniors (Kennedy, 4/24).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.